Mastering ELISpot and FluoroSpot
Are you ready to take your ELISpot and FluoroSpot expertise to the next level?
We invite you to an exclusive, hands-on training course at our Burlington, Massachusetts office, designed specifically for immunology researchers and experienced assay users. Whether you're working with T cell responses, cytokine profiling, or vaccine evaluation, this course will equip you with practical tools and in-depth insights to optimize your experiments and sharpen your results. Please note this course is intended for scientists with some experience in assay development and data analysis, and will cover these topics as they pertain to ELISpot and FluoroSpot in greater depth.
Why attend?
This immersive two-day experience is tailored for users already familiar with our products and techniques, offering a rare opportunity to dive deeper into assay performance, data interpretation, and experimental design. You’ll work closely with MilliporeSigma, Mabtech, and ZellNet scientists, troubleshoot real-world scenarios, and leave with practical know-how that can make a real difference in your lab.
This course is ideal for researchers who use ELISpot or FluoroSpot in their current projects and want to optimize their current workflows.
What you can expect:
- Hands-on lab sessions to improve technique and confidence
- Expert guidance on workflow optimization and common pitfalls
- Opportunity to develop proficiency in the emerging field of FluoroSpot
- Familiarization with the latest research software and instrumentation
- Interactive discussions on study planning, data analysis, and troubleshooting
- Peer-to-peer networking with other experienced ELISpot and FluoroSpot users
- Ongoing partnership for continued guidance and support
Course details
- May 12-13, 2026
Venue
MilliporeSigma
400 Summit Dr.
Burlington, MA 01803
USA
The Life Science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the United States and Canada.
Instructors
Spencer Keilich
Spencer Keilich, Ph.D. is a R&D scientist at MilliporeSigma. He studied Biomedical Science and Immunology at the University of Connecticut School of Medicine focusing on the impacts of influenza on older adults and vaccination. He performed development and validation research at Quantitative Cell Diagnostics (QCDx) investigating circulating tumor cells and rare cell events. Since joining MilliporeSigma in 2021, his primary works have focused on novel detection technologies and cell-based assays.
Bryan Simmons
Bryan Simons completed his PhD in Toxicology at the University of Montana in 2015. In 2017, he joined the Labcorp – Madison Immunology & Immunotoxicology group as a subject matter expert in flow cytometry and cell-based assays. Since 2022, he has led a team of SMEs focused on developing and validating cell-based assays for investigating immunotoxicity and therapeutic potential of new drug products ranging from large molecules to cell and gene therapies.
Renata Varnaite
Renata Varnaite completed her PhD in Medical Science at Karolinska Institute, Sweden in 2022. During her research studies, she utilized FluoroSpot assays to measure human T-cell and B-cell responses to infections and vaccines. Having joined Mabtech in 2023 she helps Mabtech’s customers to effectively apply ELISpot/FluoroSpot technology in different therapeutic areas, from infectious disease vaccines to cell and gene therapies.
Sylvia Janetzki
Sylvia Janetzki, MD, is President and CEO of ZellNet Consulting and one of the leading authorities on ELISpot and FluoroSpot assay development, validation, and standardization. In collaboration with the Cancer Research Institute, Dr. Janetzki established international proficiency panels for ELISpot, multimer staining, and ICS—efforts that resulted in widely adopted harmonization guidelines across the field. She is a core member of the MIATA initiative, promoting transparent and structured reporting of immune‑monitoring data. Her scientific contributions include numerous peer‑reviewed publications, book chapters, and a comprehensive reference book on ELISpot. Dr. Janetzki earned her MD from Humboldt University in Berlin and completed postdoctoral training in Immunology at Fordham University and Memorial Sloan Kettering Cancer Center.
Participation Fee
The course fee is $2,000, which includes two lunches, one social dinner, course material, and a course certificate.
NOTE: This fee does not include travel and accommodation costs.
Registration
To submit a participation request, sign up below and complete the form. Please Note! This session is limited to five attendees. Register ASAP for consideration.
Program Details
Day One
Day Two
如要继续阅读，请登录或创建帐户。
暂无帐户？